Terence W. Friedlander
- Oncology top 1%
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Immunology top 5%
- Co-authors
- Sandy SrinivasCharles J. RyanChristopher HoimesPamela L. ParisGayatri PremasekharanPeter H. O’DonnellJingsong ZhangMichael Ong
- Topics
- Bladder and Urothelial Cancer Treatments (50 papers)Prostate Cancer Treatment and Research (41 papers)Cancer Immunotherapy and Biomarkers (40 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- CellJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Terence W. Friedlander
101 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 1.9k
- Surgery 1.2k
- Pulmonary and Respiratory Medicine 856
- Molecular Biology 678
- Immunology 655
Countries citing papers authored by Terence W. Friedlander
This map shows the geographic impact of Terence W. Friedlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terence W. Friedlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terence W. Friedlander more than expected).
Fields of papers citing papers by Terence W. Friedlander
This network shows the impact of papers produced by Terence W. Friedlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terence W. Friedlander. The network helps show where Terence W. Friedlander may publish in the future.
Co-authorship network of co-authors of Terence W. Friedlander
This figure shows the co-authorship network connecting the top 25 collaborators of Terence W. Friedlander. A scholar is included among the top collaborators of Terence W. Friedlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terence W. Friedlander. Terence W. Friedlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 0 | |
| 10 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancerbreakdown → | 163 |
| 11 | 56 | |
| 12 | 2 | |
| 13 | 101 | |
| 14 | 12 | |
| 15 | 113 | |
| 16 | 30 | |
| 17 | 21 | |
| 18 | 18 | |
| 19 | 31 | |
| 20 | 88 |
About Terence W. Friedlander
Terence W. Friedlander is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 112 papers that have together received 3.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (50 papers), Prostate Cancer Treatment and Research (41 papers) and Cancer Immunotherapy and Biomarkers (40 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (531 citations) and Immunology (655 citations). Terence W. Friedlander has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Sandy Srinivas, Charles J. Ryan, Christopher Hoimes, Pamela L. Paris, Gayatri Premasekharan, Peter H. O’Donnell, Jingsong Zhang, Michael Ong, Srikala S. Sridhar and Joyce Antal. Their work appears in journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.